| Identification | Back Directory | [Name]
DIHYDROOUABAIN | [CAS]
1183-35-3 | [Synonyms]
dihydroouabin
DIHYDROOUABAIN
DIHYDROOUABAIN(RG)
Dihydro-g-strophatin
dihydro-g-strophathin
DIHYDRO-G-STROPHANTHIN
,11-alpha,14,19-pentahydroxy-
5-beta-20-xi-cardanolide,3-beta-((6-deoxy-alpha-l-mannopyranosyl)oxy)-1-beta,5
(20ξ)-3β-[(6-Deoxy-α-L-mannopyranosyl)oxy]-1β,5,11α,14,19-pentahydroxy-5β-cardanolide
Cardanolide, 3-[(6-deoxy-α-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-, (1β,3β,5β,11α,20ξ)-
(20xi)-3beta-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1beta,5beta,11alpha,14,19-pentahydroxycardanolide | [EINECS(EC#)]
214-663-0 | [Molecular Formula]
C29H46O12 | [MDL Number]
MFCD00049227 | [MOL File]
1183-35-3.mol | [Molecular Weight]
586.67 |
| Hazard Information | Back Directory | [Uses]
Dihydroouabain is a cardiac glycoside, a natural product found to be effective against various cancer cells. An inotropic drug and an inhibitor of sodium-potassium pump. | [Definition]
ChEBI:Dihydroouabain is a cardenolide glycoside that is ouabain in which the double bond in the lactone ring has been reduced to a single bond. It is a cardiac glycoside and a derivative of ouabain which is used as a sodium pump antagonist and exhibits ionotropic effects. It has a role as a radiosensitizing agent and an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is functionally related to an ouabain. |
|
|